Compare MEVOU & XOMAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MEVOU | XOMAP |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | N/A | 14 |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | N/A | N/A |
| Metric | MEVOU | XOMAP |
|---|---|---|
| Price | $10.01 | $26.48 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 19.7K | 1.3K |
| Earning Date | N/A | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.01 | $24.96 |
| 52 Week High | $10.50 | $27.30 |
| Indicator | MEVOU | XOMAP |
|---|---|---|
| Relative Strength Index (RSI) | 43.49 | 58.59 |
| Support Level | N/A | $26.05 |
| Resistance Level | $10.05 | $26.87 |
| Average True Range (ATR) | 0.02 | 0.21 |
| MACD | -0.00 | 0.12 |
| Stochastic Oscillator | 0.00 | 52.80 |
M Evo Global Acquisition Corp II is a blank check special purposr acquisition company.
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates. The Company's drug royalty aggregator business is mainly focused on the acquisition of early to mid-stage clinical assets. Geographically, the company operates in Switzerland, the United States, Asia Pacific, Europe, and other regions.